PTC Therapeutics Inc.

NASDAQ: PTCT · Real-Time Price · USD
49.52
-0.28 (-0.56%)
At close: Aug 19, 2025, 3:59 PM
49.11
-0.84%
After-hours: Aug 19, 2025, 07:55 PM EDT

PTC Therapeutics Revenue

PTC Therapeutics reported an annual revenue of $806.78M, reflecting a -13.97% growth. For the quarter ending June 30, 2025, PTC Therapeutics generated $178.88M in revenue.
Revenue (ttm)
806.78M
Revenue Growth
-13.97%
Price / Sales Ratio
4.3
Revenue / Employee
859.19K
Employees
939
Market Cap
3.93B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 806.78M -13.97%
Dec 31, 2023 937.82M +34.20%
Dec 31, 2022 698.8M +29.75%
Dec 31, 2021 538.59M +41.45%
Dec 31, 2020 380.77M +24.04%
Dec 31, 2019 306.98M +15.96%
Dec 31, 2018 264.73M +36.19%
Dec 31, 2017 194.39M +135.04%
Dec 31, 2016 82.7M +124.95%
Dec 31, 2015 36.77M +60.11%
Dec 31, 2014 22.96M -26.70%
Dec 31, 2013 31.33M +8.85%
Dec 31, 2012 28.78M -70.92%
Dec 31, 2011 98.96M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.